![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 231/56 | |
A61K 31/416 | |||
A61K 31/4192 | |||
A61K 31/4745 | |||
C07D 249/18 | |||
C07D 471/04 | |||
A61P 3/00 |
(11) | Patento numeris | 3126336 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 15713528.6 |
Europos patento paraiškos padavimo data | 2015-04-02 | |
(97) | Europos patento paraiškos paskelbimo data | 2017-02-08 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-05 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2015/057414 |
Data | 2015-04-02 |
(87) | Numeris | WO 2015/150564 |
Data | 2015-10-08 |
(30) | Numeris | Data | Šalis |
14305494 | 2014-04-04 | EP |
(72) |
SCHWINK, Lothar, DE
BUNING, Christian, DE
GLOMBIK, Heiner, DE
GOSSEL, Matthias, DE
KADEREIT, Dieter, DE
HALLAND, Nis, DE
LOHMANN, Matthias, DE
PÖVERLEIN, Christoph, DE
RITTER, Kurt, DE
|
(73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
(54) | SUBSTITUTED FUSED HETEROCYCLES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS |
SUBSTITUTED FUSED HETEROCYCLES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS |